Sunday, May 20, 2007

Hologic to buy Cytyc for about $6.2 billion

(Reuters) - Hologic's core business includes units focused on mammography, breast biopsy and osteoporosis assessment. Cytyc's strengths include cervical cancer screening and preterm birth screening.




"Both Hologic and Cytyc provide some of the most advanced technology addressing women's health needs," said Jack Cumming, Hologic's chairman and chief executive officer, who will be CEO of the combined firm.


Read more at Reuters.com Business News

No comments: